首页> 外文会议>IEEE Systems and Information Engineering Design Symposium >Survival analysis of carbapenemase-producing enterobacteriaceae infections in hospital patients
【24h】

Survival analysis of carbapenemase-producing enterobacteriaceae infections in hospital patients

机译:医院患者生产肠杆菌酶的生存分析

获取原文

摘要

The Centers for Disease Control and Prevention (CDC) estimate that more than two million people are sickened every year with antibiotic-resistant bacterial infections, and at least 23,000 die as a result of these infections in the U.S. alone. Carbapenem-resistant Enterobacteriaceae (CRE) are a particularly important subgroup with the ability to share genetic material, including the gene responsible for the production of carbapenemase enzyme. As a major threat to public health, CRE primarily affects sick patients in acute long-term health care facilities, such as Intensive Care Units. This study uses clinical data from a major U.S. hospital, as well as survival analysis methods to estimate time-to-colonization, patient risk of CRE colonization, and risk factors. A survival model was developed using Cox proportional-hazards regression to estimate time of infection. Additionally, we also used Kaplan-Meier estimation to approximate survival time. Our results support CDC's understanding of CRE infection. Sick patients with a history trauma and of staying in an ICU, which undergo certain procedures such as dialysis, fluoroscopy, respiratory intubation and mechanical ventilation, are more likely to get colonized by CRE. The fit was evaluated using the likelihood ratio test and we have found all our models to be significant.
机译:疾病控制和预防的中心(CDC)估计,每年有超过200万人的人在抗生素抗性细菌感染中均为减轻,并且由于美国的这些感染至少23,000个死亡。耐肠道肠杆菌(CRE)是一种特别重要的亚组,具有共享遗传物质的能力,包括负责生产碳结构酶酶的基因。作为对公共卫生的重大威胁,CRE主要影响急性长期保健设施中的病人,如重症监护单位。本研究使用来自美国医院主要的临床资料,以及估算殖民时间,患有CRE定植的患者风险的生存分析方法和危险因素。使用Cox比例危害回归开发了生存模型以估算感染时间。此外,我们还使用Kaplan-Meier估计来近似生存时间。我们的结果支持CDC对CRE感染的理解。病史创伤和留在ICU的病史患者,该患者经历了某些程序,如透析,透视,呼吸道插管和机械通气,更可能被CRE殖民殖民。使用似然比测试评估配合,我们发现所有模型都很重要。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号